For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Aethlon Medical Inc (NASDAQ: AEMD) closed the day trading at $0.54 down -1.68% from the previous closing price of $0.55. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 0.83 million shares were traded. AEMD stock price reached its highest trading level at $0.5754 during the session, while it also had its lowest trading level at $0.508.
Ratios:
For a better understanding of AEMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.08.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEMD now has a Market Capitalization of 413489 and an Enterprise Value of -1666955.
Stock Price History:
The Beta on a monthly basis for AEMD is 1.89, which has changed by -0.8333333 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, AEMD has reached a high of $8.44, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -44.80%, while the 200-Day Moving Average is calculated to be -79.71%.
Shares Statistics:
Over the past 3-months, AEMD traded about 2.98M shares per day on average, while over the past 10 days, AEMD traded about 69993 shares per day. A total of 2.60M shares are outstanding, with a floating share count of 2.24M. Insiders hold about 13.87% of the company’s shares, while institutions hold 15.43% stake in the company. Shares short for AEMD as of 1759190400 were 9420 with a Short Ratio of 0.03, compared to 1756425600 on 78059. Therefore, it implies a Short% of Shares Outstanding of 9420 and a Short% of Float of 1.4199998999999999.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.25 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$1.45 and -$3.05 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$0.57, with 1.0 analysts recommending between -$0.57 and -$0.57.
